What you need to know about the fast-mutating strains of COVID-19

It’s still unclear how successful a vaccine against SARS-CoV-2, the virus that causes Covid-19, can be.

A lot will depend on how the virus mutates. Broadly, there are two ways mutations can play out.

Scenario 1: The coronavirus is unable to evade a vaccine

Vaccines work by prompting the body to develop antibodies, which neutralize the virus by binding to it in a very specific way. Scientists are watching to see if mutations will affect this interaction. If they don’t, then there is hope that a vaccine won’t need constant updating.

ADVERTISEMENT

That same process has played out with our most effective vaccines, including the one against measles.

Scenario 2: Mutations make vaccines less effective over time

But what if the virus doesn’t get cornered like measles? If the virus mutates in a way that prevents antibodies from binding, it could make a lasting, universal vaccine difficult to create.

ADVERTISEMENT
ADVERTISEMENT
Follow the latest news and policy debates on agricultural biotech and biomedicine? Subscribe to our newsletter.

“What will happen in many viruses is you’ll get infected by Strain A; your immune system learns to recognize that surface protein, but then the virus is able to mutate in such a fashion that it still performs its function but make it so that your antibodies against Strain A no longer recognize Strain B,” Dr. [Trevor] Bedford said.

Related article:  Why intermittent fasting often doesn’t work

Versions of the virus with mutations that get around the population’s immunity are more likely to spread, and can then develop into new strains.

The takeaway: We’ll have to wait and see

ADVERTISEMENT
ADVERTISEMENT

Read the original post

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend